Design Precision Medicines

A novel technology platform for advancing
new precision medicines in oncology

About us

Nanoligent is a biotech company, spin-off of the Universitat Autònoma de Barcelona (UAB) and Institut de Recerca de l’Hospital de la Santa Creu I Sant Pau.

Our Technology

Nanoligent uses state-of-the-art protein engineering and nanobiotechnology to develop targeted drug therapy

Revolutionary Breakthrough

Nanoligent’s Groundbreaking Drug Targets CXCR4 to Halt Tumor Growth and Metastasis

Empowering Health

Empowering Health: Our Purpose-Driven Quest for Targeted Therapeutics

Our mision is to improve the life of patients by designing new medicines that selectively target the cells affected by disease. With this approach we develope treatments that are more effective and have fewer adverse effects than classical drugs.

NanoPrecision: Sculpting the Future of Oncology with Targeted Protein Conjugates

Our technology allows the design of new protein conjugates organized as nanoparticles and capable of targeting specific biological systems. This protein architecture is highly stable upon administration in vivo, allowing not only targeted systemic circulation but also site-specific drug delivery.

First drug under development

Our aim is to advance our first candidate as an affordable cancer therapy for the many with a high social impact. The technology we’ve developed holds promise beyond cancer, potentially revolutionizing targeted drug delivery towards different biomarkers.

More than just a Biotech company

We’re a team of visionaries and experts committed to changing the future of medicine. Founded in 2017 by distinguished professors Dr. A. Villaverde, Dr. E. Vázquez, Dr. R. Mangues, and entrepreneur Dr. M. Rodríguez, Nanoligent boasts a leadership team with unparalleled expertise in nanobiotechnology and oncology.

Dedication and expertise of our researchers

As we embark on this journey through the world of scientific publications, we invite you to join us in the pursuit of knowledge and the quest for solutions to some of the most pressing questions in our fields. From groundbreaking research to cutting-edge discoveries, these publications represent a collective effort to expand the frontiers of human knowledges.

Our values


We believe in what we do and we are fully devoted to it.


Superior scientific innovation - groundbreaking solutions.


Fostering synergy across diverse disciplines, academic entities, medical professionals, and external organizations.

Patient first

A deep focus in prioritizing patients and delivering personalized therapies.